Provided by Tiger Fintech (Singapore) Pte. Ltd.

INmune Bio Inc

7.92
-0.1700-2.10%
Pre-market: 7.89-0.0300-0.38%08:40 EDT
Volume:649.68K
Turnover:5.05M
Market Cap:183.83M
PE:-4.09
High:8.21
Open:7.99
Low:7.47
Close:8.09
Loading ...

BRIEF-Xpro™ Reduces Amyloid And Enhances Behavior Post

Reuters
·
11 Jun

Xpro™ Reduces Amyloid and Enhances Behavior Post Traumatic Brain Injury in an Animal Model of Alzheimer’s Disease: Supported by Department of Defense

THOMSON REUTERS
·
11 Jun

INmune Bio Inc. Announces Promising Results from XPro™ Clinical Study, Showing Reduction in Alzheimer's-like Pathology Post-TBI

Reuters
·
11 Jun

INmune Bio Inc. to Present at RBC Capital Markets Global Healthcare Conference in 2025

Reuters
·
14 May

INmune Bio Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
10 May

INmune Bio Q1 EPS $(0.43) Beats $(0.47) Estimate, Sales $50.00K Up From $14.00K YoY

Benzinga
·
09 May

INmune Bio Inc. Announces First Quarter 2025 Results and Provides Business Update

THOMSON REUTERS
·
09 May

INmune Bio Q1 Operating Income USD -9.905 Million

THOMSON REUTERS
·
09 May

INmune Bio Inc expected to post a loss of 47 cents a share - Earnings Preview

Reuters
·
05 May

INmune Bio Inc. to Report First Quarter 2025 Financial Results and Provide Corporate Update on Thursday, May 8TH

THOMSON REUTERS
·
05 May

INmune Bio Receives Favorable Patentability Opinion for CORDStrom™ Platform Technology

GlobeNewswire
·
16 Apr

INmune Bio partners with Cell, Gene Therapy Catapult to scale up CORDStrom

TIPRANKS
·
14 Apr

INmune Bio Partners with Cell and Gene Therapy Catapult to Scale Up CORDStrom™ Manufacturing for Commercial Readiness

GlobeNewswire
·
14 Apr

INmune Bio Inc. Presents Baseline Demographics and Disease Profiles of Participants in the MINDFuL Phase II Study

GlobeNewswire
·
01 Apr

INmune Bio Inc (INMB) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges

GuruFocus.com
·
28 Mar

INmune Bio Q4 EPS $(0.40) Beats $(0.53) Estimate

Benzinga
·
28 Mar

INmune Bio Inc. Announces Year End 2024 Results and Provides a Business Update

THOMSON REUTERS
·
28 Mar

Press Release: INmune Bio Inc. Announces Year End 2024 Results and Provides a Business Update

Dow Jones
·
28 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
27 Mar

INmune Bio Inc expected to post a loss of 54 cents a share - Earnings Preview

Reuters
·
25 Mar